William Kenneth Ward MD
Diabetes, Lipid Metabolism
Associate Professor, Medicine, Oregon Health and Science University School of Medicine
Join to View Full Profile
3181 Sw Sam Jackson Park RdMailcode Op05dcPortland, OR 97239
Phone+1 503-494-5732
Dr. Ward is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of WashingtonFellowship, Endocrinology, Diabetes, and Metabolism, 1982 - 1983
University of ColoradoResidency, Internal Medicine, 1978 - 1981- University of Colorado School of Medicine Anschutz Medical CampusClass of 1978
Certifications & Licensure
OR State Medical License 1986 - 2015
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2012
Clinical Trials
- Sensor-Augmented Insulin Delivery: Insulin Plus Glucagon Versus Insulin Alone Start of enrollment: 2008 Nov 01
- Continuous Glucose Monitoring to Measure Effect of Glycemic Index Start of enrollment: 2009 Apr 01
- Real-time Adaptation to Changes in Insulin Sensitivity Start of enrollment: 2010 Nov 01
Publications & Presentations
PubMed
- 6 citationsMeasuring glucose at the site of insulin delivery with a redox-mediated sensor.Peter G. Jacobs, Nichole S. Tyler, Scott M. Vanderwerf, Clara Mosquera-Lopez, Thomas Seidl
Biosensors & Bioelectronics. 2020-04-29 - 11 citationsAn Amperometric Glucose Sensor Integrated into an Insulin Delivery Cannula: In Vitro and in Vivo EvaluationW. Kenneth Ward, Gabriel Heinrich, Matthew E. Breen, Sheila Benware, Nicole Vollum
Diabetes Technology & Therapeutics. 2017-04-01 - 28 citationsEffect of Repeated Glucagon Doses on Hepatic Glycogen in Type 1 Diabetes: Implications for a Bihormonal Closed-Loop System.Jessica R. Castle, Joseph El Youssef, Parkash A. Bakhtiani, Yu Cai, Jade M. Stobbe
Diabetes Care. 2015-11-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
